Baljit Singh

Nola Hylton, Carolyn Mies, Olufunmilayo I Olopade, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Expression of cancer testis antigens in human BRCA-associated breast cancers: potential targets for immunoprevention?

Baljit Singh, S. Demaria, S. Adams, 2011, Cancer Immunology and Immunotherapy.

Role of cadmium in the regulation of AR gene expression and activity.

Baljit Singh, E. Gelmann, H. Voeller, 2002, Endocrinology.

A Pilot Surrogate End Point Biomarker Trial of Perillyl Alcohol in Breast Neoplasia

M. Ellis, B. Trock, Baljit Singh, 2004, Clinical Cancer Research.

Effects of tobacco smoke condensate on estrogen receptor-alpha gene expression and activity.

Baljit Singh, Antai Wang, M. Martin, 2007, Endocrinology.

Impact of Decalcification on Receptor Status in Breast Cancer

Baljit Singh, J. Melamed, L. Chiriboga, 2011, The Breast Journal.

Circulating plasma microRNAs as a screening method for detection of colorectal adenomas

Baljit Singh, J. Pringle, P. Wurm, 2015, The Lancet.

Impact of the addition of carboplatin and/or bevacizumab to neoadjuvant once-per-week paclitaxel followed by dose-dense doxorubicin and cyclophosphamide on pathologic complete response rates in stage II to III triple-negative breast cancer: CALGB 40603 (Alliance).

D. Berry, C. Perou, E. Winer, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Preoperative concurrent paclitaxel-radiation in locally advanced breast cancer: pathologic response correlates with five-year overall survival

Baljit Singh, S. Adams, J. Pietenpol, 2010, Breast Cancer Research and Treatment.

Breast cancer molecular subtypes: from TNBC to QNBC.

Baljit Singh, F. Deng, A. Sahin, 2016, American journal of cancer research.

Abstract S4-05: Impact of intrinsic subtype by PAM50 and other gene signatures on pathologic complete response (pCR) rates in triple-negative breast cancer (TNBC) after neoadjuvant chemotherapy (NACT) +/- carboplatin (Cb) or bevacizumab (Bev): CALGB 40603/150709 (Allianc

D. Berry, C. Perou, E. Winer, 2015 .

Abstract P2-10-01: PAM50 gene signature is prognostic for breast cancer patients treated with adjuvant anthracycline and taxane based chemotherapy

E. Mardis, C. Perou, E. Winer, 2012 .

Pasireotide, an IGF-I action inhibitor, prevents growth hormone and estradiol-induced mammary hyperplasia

Baljit Singh, D. Kleinberg, P. Ameri, 2011, Pituitary.

Elevated N-myristoyltransferase activity and expression in oral squamous cell carcinoma.

Baljit Singh, Rajendra K. Sharma, A. Shrivastav, 2007, Oncology reports.

Breast cancer in young women.

Baljit Singh, J. Cangiarella, D. Kornreich, 2008, Journal of the American College of Surgeons.

1 MicroRNAs are Novel Biomarkers for Detection of Colorectal Cancer

Baljit Singh, J. Pringle, J. Jameson, 2018 .

MicroRNAs are Novel Biomarkers for Detection of Colorectal Cancer

Baljit Singh, J. Pringle, J. Jameson, 2012 .

MicroRNA manipulation in colorectal cancer cells: from laboratory to clinical application

Baljit Singh, J. Pringle, J. Jameson, 2012, Journal of Translational Medicine.

Loss of heterozygosity in normal breast epithelial tissue and benign breast lesions in BRCA1/2 carriers with breast cancer.

Baljit Singh, C. Isaacs, R. Dickson, 2004, Cancer Genetics and Cytogenetics.

Molecular Heterogeneity and Response to Neoadjuvant Human Epidermal Growth Factor Receptor 2 Targeting in CALGB 40601, a Randomized Phase III Trial of Paclitaxel Plus Trastuzumab With or Without Lapatinib.

D. Berry, C. Perou, E. Winer, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MicroRNAs associated with initiation and progression of colonic polyp: a feasibility study.

Baljit Singh, J. Pringle, K. West, 2015, International journal of surgery.

Long Chain Fatty Acyl-CoA Synthetase 4 Is a Biomarker for and Mediator of Hormone Resistance in Human Breast Cancer

Baljit Singh, J. Zavadil, S. Adams, 2013, PloS one.

Sporadic breast cancers exhibit loss of heterozygosity on chromosome segment 10q23 close to the Cowden disease locus

Baljit Singh, M. Ittmann, J. Krolewski, 1998, Genes, chromosomes & cancer.

Stat5a is tyrosine phosphorylated and nuclear localized in a high proportion of human breast cancers

E. Gehan, Baljit Singh, P. Furth, 2004, International journal of cancer.

Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer.

Baljit Singh, D. Rimm, M. Dolled-Filhart, 2003, Cancer research.

CALGB (Alliance) 40603: Long-term outcomes (LTOs) after neoadjuvant chemotherapy (NACT) +/- carboplatin (Cb) and bevacizumab (Bev) in triple-negative breast cancer (TNBC).

D. Berry, C. Perou, E. Winer, 2019, Journal of Clinical Oncology.

Androgen receptor coactivator p44/Mep50 in breast cancer growth and invasion

Baljit Singh, Zhengxin Wang, R. Xu, 2009, Journal of cellular and molecular medicine.

Letrozole inhibits tumor proliferation more effectively than tamoxifen independent of HER1/2 expression status.

M. Ellis, Baljit Singh, Y. Tao, 2003, Cancer research.

Expression patterns among interferon regulatory factor-1, human X-box binding protein-1, nuclear factor kappa B, nucleophosmin, estrogen receptor-alpha and progesterone receptor proteins in breast cancer tissue microarrays.

Robert Clarke, Aiyi Liu, Stephen Hewitt, 2006, International journal of oncology.

A link between premenopausal iron deficiency and breast cancer malignancy

Baljit Singh, Qing Yang, L. Chiriboga, 2013, BMC Cancer.

Abstract S5-01: Impact of the addition of carboplatin (Cb) and/or bevacizumab (B) to neoadjuvant weekly paclitaxel (P) followed by dose-dense AC on pathologic complete response (pCR) rates in triple-negative breast cancer (TNBC): CALGB 40603 (Alliance)

D. Berry, C. Perou, E. Winer, 2013 .

Metaplastic breast cancers: Genomic profiling, mutational burden and tumor-infiltrating lymphocytes.

C. Denkert, Baljit Singh, A. Troxel, 2019, Breast.

Co-expression of EGFRvIII with ErbB-2 enhances tumorigenesis: EGFRvIII mediated constitutively activated and sustained signaling pathways, whereas EGF-induced a transient effect on EGFR-mediated signaling pathways

Baljit Singh, Careen K. Tang, Hong Yu, 2008, Cancer biology & therapy.

Insulin-like growth factor-I inhibition with pasireotide decreases cell proliferation and increases apoptosis in pre-malignant lesions of the breast: a phase 1 proof of principle trial

Baljit Singh, F. Darvishian, D. Axelrod, 2014, Breast Cancer Research.

Invasive lobular carcinoma of the breast: role of endothelial lymphatic marker D2-40.

Baljit Singh, J. Melamed, L. Chiriboga, 2008, Annals of clinical and laboratory science.

Increased frequency of regulatory T cells in peripheral blood and tumour infiltrating lymphocytes in colorectal cancer patients.

S. Fox, Baljit Singh, A. Banham, 2007, Cancer immunity.

Cancer and Leukemia Group B Pathology Committee guidelines for tissue microarray construction representing multicenter prospective clinical trial tissues.

D. Berry, F. Waldman, T. Nielsen, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ductal Carcinoma In Situ—Pathological Considerations

Baljit Singh, 2020, Current Breast Cancer Reports.

Abstract S2-05: Event-free and overall survival following neoadjuvant weekly paclitaxel and dose-dense AC +/- carboplatin and/or bevacizumab in triple-negative breast cancer: Outcomes from CALGB 40603 (Alliance)

D. Berry, C. Perou, E. Winer, 2016 .

Accurate genotyping from paraffin-embedded normal tissue adjacent to breast cancer.

Baljit Singh, J. Freudenheim, P. Shields, 2006, Carcinogenesis.

Expression of the nuclear coactivator AIB1 in normal and malignant breast tissue

Baljit Singh, A. Wellstein, A. Riegel, 2001, Breast Cancer Research and Treatment.

Prognostic and Predictive Value of Immune-Related Gene Expression Signatures vs Tumor-Infiltrating Lymphocytes in Early-Stage ERBB2/HER2-Positive Breast Cancer

C. Perou, K. Hoadley, Baljit Singh, 2023, JAMA oncology.

Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy.

Baljit Singh, F. Esteva, P. Levine, 2016, Clinical breast cancer.

Distinct breast cancer subtypes in women with early-onset disease across races.

Baljit Singh, D. Doval, F. Deng, 2014, American journal of cancer research.

CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer

Sara R. Selitsky, C. Fan, C. Perou, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Accurate Estrogen Receptor Quantification in Patients with Negative and Low-Positive Estrogen-Receptor-Expressing Breast Tumors: Sub-Analyses of Data from Two Clinical Studies

Baljit Singh, F. Baehner, D. Cameron, 2019, Advances in Therapy.

The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group

Andrew H. Beck, Clare C. Yu, M. N. Vidya, 2021, npj Breast Cancer.

Progressive Loss of Syk and Abnormal Proliferation in Breast Cancer Cells

Li Zhang, Ying Zhang, Edmund Gehan, 2004, Cancer Research.

Nipple‐sparing Mastectomy and Sub‐areolar Biopsy: To Freeze or not to Freeze? Evaluating the Role of Sub‐areolar Intraoperative Frozen Section

Baljit Singh, D. Roses, M. Alperovich, 2016, The breast journal.

The "two-week wait" referral pathway is not associated with improved survival for patients with colorectal cancer.

Baljit Singh, S. Chaudhri, J. Jameson, 2017, International journal of surgery.

Preoperative therapy in invasive breast cancer: pathologic assessment and systemic therapy issues in operable disease.

E. Winer, G. Hortobagyi, Baljit Singh, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pathology Issues Related to Neoadjuvant Treatment and the Evaluation of Pathological Response

Baljit Singh, 2005 .

Circulating tumor DNA in patients with colorectal adenomas: assessment of detectability and genetic heterogeneity

P. Tarpey, Baljit Singh, U. McDermott, 2018, Cell Death & Disease.

Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials

Jacqueline A. Hall, Sarah N. Dudgeon, A. Gown, 2020, npj Breast Cancer.

A prospective randomized pilot study to evaluate predictors of response in serial core biopsies to single agent neoadjuvant doxorubicin or paclitaxel for patients with locally advanced breast cancer.

Baljit Singh, C. Isaacs, D. Hayes, 2003, Clinical Cancer Research.

Microinvasive Breast Cancer and the Role of Sentinel Node Biopsy: An Institutional Experience and Review of the Literature

Baljit Singh, D. Roses, J. Cangiarella, 2008, The breast journal.

Comparison of residual cancer burden, American Joint Committee on Cancer staging and pathologic complete response in breast cancer after neoadjuvant chemotherapy: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)

Jeffrey I. Campbell, L. Esserman, Baljit Singh, 2017, Breast Cancer Research and Treatment.

Evaluating the incidence of pathological complete response in current international rectal cancer practice: the barriers to widespread safe deferral of surgery

M. Morino, C. Buskens, W. Bemelman, 2018, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Activation of Signal Transducer and Activator of Transcription 5 in Human Prostate Cancer Is Associated with High Histological Grade

M. LeBaron, E. Ealley, M. Nevalainen, 2004, Cancer Research.

Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial.

D B Evans, M. Ellis, Baljit Singh, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Decade of Change: An Institutional Experience with Breast Surgery in 1995 and 2005

Baljit Singh, D. Roses, J. Cangiarella, 2008, Breast cancer : basic and clinical research.

Circulating tumor DNA in patients with colorectal adenomas: assessment of detectability and genetic heterogeneity

P. Tarpey, Baljit Singh, U. McDermott, 2018, Cell Death & Disease.

Impact of Decalcification on Receptor Status in Breast Cancer

Baljit Singh, J. Melamed, L. Chiriboga, 2011, The breast journal.